Mudit Gupta

Mudit Gupta

Active Director Additional Director DIN 07779276
DIN 07779276 First appointment Jun 2018 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 2 active board seats
Past companies 3 historical roles
Total affiliations 5 Since Jun 2018
Shareholding value •••• Premium profile

About Mudit Gupta

Data last updated:

Mudit Gupta is an Additional Director at Saral Advanced Diagnostic Private Limited (since 2025) and Director at Classic Diagnostics Private Limited (since 2023). The companies operate in Healthcare and Food and Beverages. The 2 current companies with reported revenue have a combined latest revenue of ₹24.08 Cr; the largest is Saral Advanced Diagnostic Private Limited at ₹13.11 Cr (FY 2024). Earlier, Mudit Gupta was a Managing Director at Saral Dx (Opc) Private Limited (2021–2022) and Director at Inika Foods Private Limited (2018–2020) and 1 more.

DIN 07779276
Primary Designation Additional Director
Industry Healthcare
First Appointment 27 Jun 2018
Oldest Company Age 28 yrs
Largest company Saral Advanced Diagnostic Private Limited · ₹13.11 Cr (FY 2024)
Combined revenue ₹24.08 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Additional Director06 May 20251998₹13.11 Cr (FY 2024)Active
Classic Diagnostics Private Limited U93000DL2017PTC317430
Director17 Aug 20232017₹10.97 Cr (FY 2024)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Saral Dx (Opc) Private Limited U85300DL2021OPC381847
Managing Director03 Jun 20212021₹28.67 Cr (FY 2024)Amalgamated
Inika Foods Private Limited U15549DL2018PTC335844
Director27 Jun 20182018₹8.9 Lakh (FY 2021)Active
Inika Consultancy Private Limited U93000DL2018PTC339386
Director24 Sep 20182018₹2.3 Lakh (FY 2020)Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Inika Consultancy Private Limited
Saral Advanced Diagnostic Private Limited
Classic Diagnostics Private Limited
Saral Dx (Opc) Private Limited
Premium access

Shareholding and investment profile for Mudit Gupta

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mudit Gupta

Mudit Gupta currently holds 2 directorships: Saral Advanced Diagnostic Private Limited (Additional Director, since 06 May 2025, revenue ₹13.11 Cr (FY 2024)); Classic Diagnostics Private Limited (Director, since 17 Aug 2023, revenue ₹10.97 Cr (FY 2024)).

Mudit Gupta was first appointed on 27 Jun 2018 as Director at Inika Foods Private Limited. The most recent appointment on record is 06 May 2025 at Saral Advanced Diagnostic Private Limited.

The 2 current companies of Mudit Gupta that report revenue have a combined latest revenue of ₹24.08 Cr: Saral Advanced Diagnostic Private Limited ₹13.11 Cr (FY 2024); Classic Diagnostics Private Limited ₹10.97 Cr (FY 2024).

Mudit Gupta held 3 earlier board appointments: Saral Dx (Opc) Private Limited (Managing Director, 03 Jun 2021 to 15 Oct 2022); Inika Foods Private Limited (Director, 27 Jun 2018 to 21 Jan 2020); Inika Consultancy Private Limited (Director, from 24 Sep 2018).

The current boards of Mudit Gupta's companies include Kamal Krishan Trehan (Saral Advanced Diagnostic Private Limited), Ravi Kumar Gupta (Saral Advanced Diagnostic Private Limited), Vijay Giridher (Saral Advanced Diagnostic Private Limited), Akshay Bhasin (Classic Diagnostics Private Limited), Neena Bhasin (Classic Diagnostics Private Limited), Rakesh Bhasin (Classic Diagnostics Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available